Table 1 MM and non-obstructive hypertrophic cardiomyopathy patients MRI results compared

Age (years)

49.9 ± 18.0

51.7 ± 12.4

60.0 ± 8.9

0.18

0.36

Gender (M/F)

16/10

16/10

9/7

0.73

0.73

LVEDV (ml/m²)

117.5 ± 25.9

156.7 ± 49.8

100.6 ± 33.8

0.338

0.001

LVESV (ml/m²)

52.7 ± 16.3

96.7 ± 50.3

53.6 ± 25.7

0.995

0.004

LVEF (%)

55.6 ± 10.3

40.4 ± 15.6

49.1 ± 17.5

0.314

0.206

LVM (g)

109.0 ± 27.0

232.4 ± 89.8

156.9 ± 50.6

0.05

0.005

LVPWT (> 12 mm)

-

26(100%)

14(87.5%)

< 0.001

0.06

Mitralvalvular regurgitation

-

21(80.7%)

16(100%)

< 0.001

0.138

Perfusion defects

-

-

7(43.5%)

0.002

0.002

LGE

-

19(73.1%)

16(100%)

< 0.001

0.02

Native T1 (ms)

1269.3 ± 42.3

1324.0 ± 45.1

1462.0 ± 71.3

< 0.001

< 0.001

Enhanced T1 (ms)

516.0 ± 61.1

499.0 ± 65.9

479.3 ± 66.7

0.428

0.825

ECV (%)

27.7 ± 2.3

29.2 ± 4.3

45.7 ± 6.7

< 0.001

< 0.001

Pericardial effusion

-

-

6(37.5%)

< 0.001

< 0.001

Pleural effusion

-

9(56.3%)

< 0.001

< 0.001